All Stories

  1. Exposure to valproic acid is associated with less pulmonary infiltrates and improvements in diverse clinical outcomes and laboratory parameters in patients hospitalized with COVID-19

    Article • PLoS ONE, January 2022, PLOS

    Dr Victor Asensi

  2. The N125S polymorphism in the cathepsin G gene (rs45567233) is associated with susceptibility to osteomyelitis in a Spanish population

    Article • PLoS ONE, October 2019, PLOS

    Dr Victor Asensi

  3. Decreasing rates of acute myocardial infarction in people living with HIV: a nationwide cohort study in Spain, 2004-2015

    Article • HIV Medicine, April 2018, Wiley

    Dr Victor Asensi

  4. Malthus Mysterious Orofacial Cleft Correction

    Article • The Cleft Palate-Craniofacial Journal, March 2018, SAGE Publications

    Dr Victor Asensi

  5. Clinical, epidemiological and treatment failure data among HIV-1 non-B-infected patients in the Spanish AIDS Research Network Cohort

    Article • Enfermedades Infecciosas y Microbiología Clínica, June 2016, Elsevier

    Dr Victor Asensi

  6. Factors associated with long-term CD4 cell recovery in HIV-infected patients on successful antiretroviral therapy

    Article • HIV Medicine, January 2016, Wiley

    Dr Victor Asensi

  7. The effect of gender and genetic polymorphisms on matrix metalloprotease (MMP) and tissue inhibitor (TIMP) plasma levels in different infectious and non-infectious conditions

    Article • Clinical & Experimental Immunology, September 2015, Wiley

    Dr Victor Asensi

  8. Improvement of lipoatrophy by switching from efavirenz to lopinavir/ritonavir

    Article • HIV Medicine, September 2015, Wiley

    Dr Victor Asensi

  9. HIV/antiretroviral therapy–related lipodystrophy syndrome (HALS) is associated with higher RBP4 and lower omentin in plasma

    Article • Clinical Microbiology and Infection, July 2015, Elsevier

    Dr Victor Asensi

  10. CD4+CD28null T lymphocytes resemble CD8+CD28null T lymphocytes in their responses to IL-15 and IL-21 in HIV-infected patients

    Article • Journal of Leukocyte Biology, June 2015, Society for Leukocyte Biology

    Dr Victor Asensi

  11. Can antiretroviral therapy be tailored to each human immunodeficiency virus-infected individual? Role of pharmacogenomics

    Article • World Journal of Virology, January 2015, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Victor Asensi

  12. Differential Body Composition Effects of Protease Inhibitors Recommended for Initial Treatment of HIV Infection: A Randomized Clinical Trial

    Article • Clinical Infectious Diseases, November 2014, Oxford University Press (OUP)

    Dr Victor Asensi

  13. Endothelial (NOS3 E298D) and inducible (NOS2 exon 22) nitric oxide synthase polymorphisms, as well as plasma NOx, influence sepsis development

    Article • Nitric Oxide, November 2014, Elsevier

    Dr Victor Asensi

  14. Role of plasma matrix-metalloproteases (MMPs) and their polymorphisms (SNPs) in sepsis development and outcome in ICU patients

    Article • Scientific Reports, May 2014, Nature

    Dr Victor Asensi

  15. Abacavir/lamivudine plus darunavir/ritonavir in routine clinical practice: a multicentre experience in antiretroviral therapy-naive and -experienced patients

    Article • Journal of Antimicrobial Chemotherapy, May 2014, Oxford University Press (OUP)

    Dr Victor Asensi

  16. Immune Reconstitution Inflammatory Syndrome-Unmasking Endophthalmic, Lymphadenopathic, and Neuromeningeal Cryptococcosis in an HIV-Infected Patient Starting Highly Active Antiretroviral Therapy

    Article • AIDS Research and Human Retroviruses, May 2014, Mary Ann Liebert Inc

    Dr Victor Asensi

  17. Involvement of the LPS-LPB-CD14-MD2-TLR4 inflammation pathway in HIV-1/HAART-associated lipodystrophy syndrome (HALS)

    Article • Journal of Antimicrobial Chemotherapy, February 2014, Oxford University Press (OUP)

    Dr Victor Asensi

  18. Risk of clinically significant depression in HIV-infected patients: effect of antiretroviral drugs

    Article • HIV Medicine, November 2013, Wiley

    Dr Victor Asensi, Dr. Vicente Soriano

  19. Efficacy and Tolerability of Darunavir/Ritonavir in Combination with Abacavir/Lamivudine: An Option in Selected HIV-Infected Patients

    Article • HIV Clinical Trials, October 2013, Taylor & Francis

    Dr Victor Asensi

  20. tPA Alu (I/D) Polymorphism Associates With Bacterial Osteomyelitis

    Article • The Journal of Infectious Diseases, April 2013, Oxford University Press (OUP)

    Dr Victor Asensi

  21. Euler's Right Eye: The Dark Side of a Bright Scientist

    Article • Clinical Infectious Diseases, March 2013, Oxford University Press (OUP)

    Dr Victor Asensi

  22. The Effect of Unsuccessful Treatment with Peginterferon and Ribavirin on the Liver Fibrosis Course of HIV/HCV-Coinfected Patients

    Article • Current HIV Research, November 2012, Bentham Science Publishers

    Dr Victor Asensi

  23. Course of Liver Fibrosis in HIV-Hepatitis C Virus-Coinfected Patients Depending on the Response to Hepatitis C Therapy

    Article • AIDS Research and Human Retroviruses, July 2012, Mary Ann Liebert Inc

    Dr Victor Asensi

  24. Comparison of High Ribavirin Induction Versus Standard Ribavirin Dosing, Plus Peginterferon-  for the Treatment of Chronic Hepatitis C in HIV-Infected Patients: The PERICO Trial

    Article • The Journal of Infectious Diseases, July 2012, Oxford University Press (OUP)

    Dr Victor Asensi, Dr. Vicente Soriano

  25. Definition of Advanced Age in HIV-Infection: Looking for an Age Cut-Off.

    Article • AIDS Research and Human Retroviruses, May 2012, Mary Ann Liebert Inc

    Dr Victor Asensi, Dr. Vicente Soriano

  26. Didanosine (ddI) associates with increased liver fibrosis in adult HIV-HCV coinfected patients

    Article • Journal of Viral Hepatitis, March 2012, Wiley

    Dr Victor Asensi

  27. Infección combinada por virus de la inmunodeficiencia humana y enfermedad de Chagas tratada satisfactoriamente con benznidazol y una pauta de tratamiento antirretroviral basada en raltegravir: descripción de un caso

    Article • Medicina Clínica, September 2011, Elsevier

    Dr Victor Asensi

  28. The IL-1β (+3953 T/C) gene polymorphism associates to symptomatic lumbar disc herniation

    Article • European Spine Journal, August 2011, Springer Science + Business Media

    Dr Victor Asensi

  29. Gender Differences in Liver Fibrosis and Hepatitis C Virus-Related Parameters in Patients Coinfected with Human Immunodeficiency Virus

    Article • Current HIV Research, July 2011, Bentham Science Publishers

    Dr Victor Asensi

  30. Immunological Status Does Not Influence Hepatitis C Virus or Liver Fibrosis in HIV-Hepatitis C Virus-Coinfected Patients

    Article • AIDS Research and Human Retroviruses, April 2011, Mary Ann Liebert Inc

    Dr Victor Asensi

  31. No Relationship Between TNF-α Genetic Variants and Combination Antiretroviral Therapy-Related Lipodystrophy Syndrome in HIV Type 1-Infected Patients: A Case-Control Study and a Meta-Analysis

    Article • AIDS Research and Human Retroviruses, February 2011, Mary Ann Liebert Inc

    Dr Victor Asensi

  32. Factors associated with liver fibrosis in intravenous drug users coinfected with HIV and HCV

    Article • Antiviral Therapy, January 2011, International Medical Press

    Dr Victor Asensi

  33. Sustained virological response in HIV/HCV co-infected patients without rapid virological response (RVR) on peginterferon-ribavirin therapy

    Article • Journal of the International AIDS Society, November 2010, Wiley

    Dr Victor Asensi, Dr. Vicente Soriano

  34. Evaluation of the possible influence of hepatitis C virus and liver fibrosis on HIV type 1 immunological and virological outcomes

    Article • HIV Medicine, October 2010, Wiley

    Dr Victor Asensi

  35. The MMP1 (−16071G/2G) single nucleotide polymorphism associates with the HAART-related lipodystrophic syndrome

    Article • AIDS, October 2010, Wolters Kluwer Health

    Dr Victor Asensi

  36. Effect of simplification from protease inhibitors to boosted atazanavir-based regimens in real-life conditions

    Article • HIV Medicine, September 2010, Wiley

    Dr Victor Asensi

  37. Asociación entre el polimorfismo genético de la interleucina-1β (3953 T/C) y la hernia discal lumbar sintomática

    Article • Revista Española de Cirugía Ortopédica y Traumatología, July 2010, Elsevier

    Dr Victor Asensi

  38. Screening for Chagas' disease in HIV-positive immigrants from endemic areas

    Article • Epidemiology and Infection, June 2010, Cambridge University Press

    Dr Victor Asensi

  39. Meropenem monotherapy is as effective as and safer than imipenem to treat brain abscesses

    Article • International Journal of Antimicrobial Agents, March 2010, Elsevier

    Dr Victor Asensi

  40. Association between the genetic polymorphism of interleukin-1ß (3953 T/C) and symptomatic lumbar herniated disc

    Article • Revista Española de Cirugía Ortopédica y Traumatología (English Edition), January 2010, Elsevier

    Dr Victor Asensi

  41. Association of HIV transmission categories with sociodemographic, viroimmunological and clinical parameters of HIV-infected patients

    Article • Epidemiology and Infection, November 2009, Cambridge University Press

    Dr Victor Asensi

  42. A Functional Polymorphism inMMP1Could Influence Osteomyelitis Development

    Article • Journal of Bone and Mineral Research, October 2009, Wiley

    Dr Victor Asensi

  43. Abscesos abdominales y retroperitoneales en paciente con carcinoma vesical en tratamiento con bacilo de Calmette y Guérin

    Article • Enfermedades Infecciosas y Microbiología Clínica, October 2009, Elsevier

    Dr Victor Asensi

  44. CD8dim and NKG2D Expression Defines Related Subsets of CD4+ T cells in HIV-Infected Patients With Worse Prognostic Factors

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, August 2009, Wolters Kluwer Health

    Dr Victor Asensi, Prof. Luis Rodrigo

  45. CD4 Responses in the Setting or Suboptimal Virological Responses to Antiretroviral Therapy: Features, Outcomes, and Associated Factors

    Article • AIDS Research and Human Retroviruses, July 2009, Mary Ann Liebert Inc

    Dr Victor Asensi

  46. 227 NON-CIRRHOTIC PORTAL HYPERTENSION IN HIV-INFECTED PATIENTS

    Article • Journal of Hepatology, April 2009, Elsevier

    Dr Victor Asensi, Dr. Vicente Soriano

  47. The influence of the patients’ educational levels on socioeconomic, clinical, immunological and virological endpoints

    Article • AIDS Care, April 2009, Taylor & Francis

    Dr Victor Asensi

  48. Didanosine, Lamivudine, and Efavirenz versus Zidovudine, Lamivudine, and Efavirenz for the Initial Treatment of HIV Type 1 Infection: Final Analysis (48 Weeks) of a Prospective, Randomized, Noninferiority Clinical Trial, GESIDA 3903

    Article • Clinical Infectious Diseases, October 2008, Oxford University Press (OUP)

    Dr Victor Asensi

  49. In vivo treatment with anti B-220 monoclonal antibody affects T and B cell differentiation

    Article • Clinical & Experimental Immunology, June 2008, Wiley

    Dr Victor Asensi

  50. Incidence of anaemia and impact on sustained virological response in HIV/HCV-coinfected patients treated with pegylated interferon plus ribavirin

    Article • Journal of Viral Hepatitis, May 2008, Wiley

    Dr Victor Asensi, Dr. Vicente Soriano

  51. Autoregulation mechanism of human neutrophil apoptosis during bacterial infection☆

    Article • Molecular Immunology, April 2008, Elsevier

    Dr Victor Asensi

  52. IL-1β (+3954C/T) polymorphism could protect human immunodeficiency virus (HIV)-infected patients on highly active antiretroviral treatment (HAART) against lipodystrophic syndrome

    Article • Genetics in Medicine, March 2008, Nature

    Dr Victor Asensi

  53. Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments

    Article • Journal of Antimicrobial Chemotherapy, February 2008, Oxford University Press (OUP)

    Dr Victor Asensi

  54. Efficacy and Safety of a Once Daily Regimen with Efavirenz, Lamivudine, and Didanosine, with and without Food, as Initial Therapy for HIV Infection: The ELADI Study

    Article • AIDS Research and Human Retroviruses, October 2007, Mary Ann Liebert Inc

    Dr Victor Asensi, Dr. Vicente Soriano

  55. Role of Weight-Based Ribavirin Dosing and Extended Duration of Therapy in Chronic Hepatitis C in HIV-Infected Patients: The PRESCO Trial

    Article • AIDS Research and Human Retroviruses, August 2007, Mary Ann Liebert Inc

    Dr Victor Asensi, Dr. Vicente Soriano

  56. Factors Associated with Poor Immunologic Responses Despite Viral Suppression in Markedly Immunosuppressed Patients

    Article • AIDS Patient Care and STDs, June 2007, Mary Ann Liebert Inc

    Dr Victor Asensi

  57. Sex differences in the clinical, immunological and virological parameters of HIV-infected patients treated with HAART

    Article • AIDS, April 2007, Wolters Kluwer Health

    Dr Victor Asensi

  58. [591] IMPACT OF ANEMIA AND ZIDOVUDINE USE ON SUSTAINED VIROLOGICAL RESPONSE IN A TRIAL OF PEGYLATED INTERFERON PLUS RIBAVIRIN IN HIV/HCV-COINFECTED PATIENTS

    Article • Journal of Hepatology, April 2007, Elsevier

    Dr Victor Asensi, Dr. Vicente Soriano

  59. Bax gene G(-248)A promoter polymorphism is associated with increased lifespan of the neutrophils of patients with osteomyelitis

    Article • Genetics in Medicine, April 2007, Nature

    Dr Victor Asensi

  60. P1345 Multidrug-resistant Acinetobacter baumannii prosthetic joint infection treated with colistin

    Article • International Journal of Antimicrobial Agents, March 2007, Elsevier

    Dr Victor Asensi

  61. The NOS3 (27-bp repeat, intron 4) polymorphism is associated with susceptibility to osteomyelitis

    Article • Nitric Oxide, February 2007, Elsevier

    Dr Victor Asensi

  62. Cervical lipomatosis in HIV-infected patients: a case?control study

    Article • HIV Medicine, January 2007, Wiley

    Dr Victor Asensi

  63. Association between Physical and Echographic Fat Thickness Assessments and a Lipodystrophy Grading Scale in Lipodystrophic HIV Patients: Practical Implications

    Article • AIDS Research and Human Retroviruses, September 2006, Mary Ann Liebert Inc

    Dr Victor Asensi

  64. Post-surgical enterococcal meningitis: Clinical and epidemiological study of 20 cases

    Article • Scandinavian Journal of Infectious Diseases, August 2006, Taylor & Francis

    Dr Victor Asensi

  65. Influence of HCV Genotype in Isolated Presence of Antibody to Hepatitis B Core Antigen in Patients With HIV Coinfection

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, August 2006, Wolters Kluwer Health

    Dr Victor Asensi

  66. The Toll-like receptor 4 (Asp299Gly) polymorphism is a risk factor for Gram-negative and haematogenous osteomyelitis

    Article • Clinical & Experimental Immunology, March 2006, Wiley

    Dr Victor Asensi

  67. Recomendaciones de GEAM/SPNS sobre el tratamiento de las alteraciones metabólicas y morfológicas en el paciente con infección por VIH

    Article • Enfermedades Infecciosas y Microbiología Clínica, February 2006, Elsevier

    Dr Victor Asensi

  68. Reply to Gulizia et al

    Article • Clinical Infectious Diseases, January 2005, Oxford University Press (OUP)

    Dr Victor Asensi

  69. Estudio comparativo de la meningitis posquirúrgica por Staphylococcus aureus sensible y resistente a meticilina

    Article • Medicina Clínica, January 2005, Elsevier

    Dr Victor Asensi

  70. Hepatocellular carcinoma in HIV-infected patients

    Article • AIDS, November 2004, Wolters Kluwer Health

    Dr Victor Asensi, Dr. Vicente Soriano

  71. Isolated Presence of Antibody to Hepatitis B Core Antigen in Patients Coinfected With HIV

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, August 2004, Wolters Kluwer Health

    Dr Victor Asensi

  72. Perirenal Fat Diameter Measured by Echography Could Be an Early Predictor of Lipodystrophy in HIV Type 1--Infected Patients Receiving Highly Active Antiretroviral Therapy

    Article • Clinical Infectious Diseases, July 2004, Oxford University Press (OUP)

    Dr Victor Asensi

  73. In Vivo Interleukin-6 Protects Neutrophils from Apoptosis in Osteomyelitis

    Article • Infection and Immunity, July 2004, ASM Journals

    Dr Victor Asensi

  74. Grado de replicación del virus de la hepatitis C y aparición de hepatotoxicidad por nevirapina en pacientes con infección por el VIH

    Article • Medicina Clínica, March 2004, Elsevier

    Dr Victor Asensi

  75. Grado de replicación del virus de la hepatitis C y aparición de hepatotoxicidad por nevirapina en pacientes con infección por el VIH

    Article • Medicina Clínica, January 2004, Elsevier

    Dr Victor Asensi

  76. Incidence and Predictors of Severe Liver Fibrosis in Human Immunodeficiency Virus–Infected Patients with Chronic Hepatitis C: A European Collaborative Study

    Article • Clinical Infectious Diseases, January 2004, Oxford University Press (OUP)

    Dr Victor Asensi, Dr. Vicente Soriano

  77. Consensus conference on chronic viral hepatitis and HIV infection: updated Spanish recommendations

    Article • Journal of Viral Hepatitis, January 2004, Wiley

    Dr Victor Asensi, Dr. Vicente Soriano

  78. Treatment of Chronic Hepatitis C in HIV-Infected Patients with Interferon α -2b Plus Ribavirin

    Article • AIDS Research and Human Retroviruses, December 2003, Mary Ann Liebert Inc

    Dr Victor Asensi, Dr. Vicente Soriano

  79. Factors Influencing the Development of Lipodystrophy in Human Immunodeficiency Virus-infected Patients

    Article • Scandinavian Journal of Infectious Diseases, May 2003, Taylor & Francis

    Dr Victor Asensi

  80. IL-1α (− 889) promoter polymorphism is a risk factor for osteomyelitis

    Article • American Journal of Medical Genetics Part A, April 2003, Wiley

    Dr Victor Asensi

  81. An open-label, multicenter study of efficacy and safety of peginterferon alfa-2a/ribavirin in HIV/HCV coinfection

    Article • Journal of Hepatology, April 2003, Elsevier

    Dr Victor Asensi

  82. Histological damage in liver biopsy specimens from 492 HIV-HCV co-infected patients: A European collaborative study

    Article • Journal of Hepatology, April 2003, Elsevier

    Dr Victor Asensi, Dr. Vicente Soriano

  83. Hepatitis C Virus in Patients With HIV Infection and Lipodystrophy

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, March 2003, Wolters Kluwer Health

    Dr Victor Asensi

  84. Eikenella corrodens Brain Abscess after Repeated Periodontal Manipulations Cured with Imipenem and Neurosurgery

    Article • Infection, August 2002, Springer Science + Business Media

    Dr Victor Asensi

  85. Triglyceride increase can predict lipodystrophy in HIV patients under highly active antiretroviral therapy

    Article • AIDS, July 2002, Wolters Kluwer Health

    Dr Victor Asensi

  86. Efficacy and safety of combination therapy with interferon plus ribavirin in HIV-infected patients with chronic hepatitis C

    Article • Journal of Hepatology, April 2002, Elsevier

    Dr Victor Asensi, Dr. Vicente Soriano

  87. AIDS-related Kaposi's sarcoma with chylothorax and pericardial involvement satisfactorily treated with liposomal doxorubicin

    Article • AIDS, March 2002, Wolters Kluwer Health

    Dr Victor Asensi

  88. Interrupción del tratamiento antirretroviral en la práctica clínica

    Article • Medicina Clínica, January 2002, Elsevier

    Dr Victor Asensi

  89. Meningitis por Streptococcus suis. A propósito de dos casos y revisión de la literatura

    Article • Enfermedades Infecciosas y Microbiología Clínica, January 2001, Elsevier

    Dr Victor Asensi

  90. Meningitis postquirúrgica por Acinetobacter baumannii: estudio de 22 casos y revisión de la literatura

    Article • Revista Clínica Española, January 2001, Elsevier

    Dr Victor Asensi

  91. Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C

    Article • The American Journal of Gastroenterology, January 2001, Nature

    Dr Victor Asensi, Dr. Vicente Soriano

  92. Mycobacterium avium Complex Cervical Lymphadenitis in an Immunocompetent Adult Patient

    Article • Journal of Infection, September 2000, Elsevier

    Dr Victor Asensi

  93. Visceral Leishmaniasis and Other Severe Infections in an Adult Patient with p47- phox -Deficient Chronic Granulomatous Disease

    Article • Infection, May 2000, Springer Science + Business Media

    Dr Victor Asensi

  94. Meningitis postquirúrgica por Pseudomonas aeruginosa: estudio de 15 casos y revisión de la literatura

    Article • Revista Clínica Española, January 2000, Elsevier

    Dr Victor Asensi

  95. Successful intrathecal ethanol block for intractable spasticity of AIDS-related progressive multifocal leukoencephalopathy

    Article • Spinal Cord, June 1999, Nature

    Dr Victor Asensi

  96. Lamivudine for chronic hepatitis B and HIV co-infection

    Article • AIDS, May 1999, Wolters Kluwer Health

    Dr Victor Asensi

  97. Cytomegalovirus Antigenemia Surveillance in the Treatment of Cytomegalovirus Disease in AIDS Patients

    Article • Journal of Chemotherapy, January 1999, Taylor & Francis

    Dr Victor Asensi

  98. Prosthetic joint infection byPasteurella multocida

    Article • European Journal of Clinical Microbiology & Infectious Diseases, August 1997, Springer Science + Business Media

    Dr Victor Asensi

  99. Bactericidal Effect of ADP and Acetic Acid on Bacillus subtilis

    Article • Current Microbiology, January 1997, Springer Science + Business Media

    Dr Victor Asensi

  100. Imipenem therapy of brain abscesses

    Article • European Journal of Clinical Microbiology & Infectious Diseases, August 1996, Springer Science + Business Media

    Dr Victor Asensi

  101. Answer to Photo Quiz

    Article • Clinical Infectious Diseases, April 1996, Oxford University Press (OUP)

    Dr Victor Asensi

  102. Therapy of brain abscess with impienem—a safe therapeutic choice?

    Article • Journal of Antimicrobial Chemotherapy, January 1996, Oxford University Press (OUP)

    Dr Victor Asensi

  103. Myasthenia Gravis and Systemic Lupus Erythematosus in Association with Human Immunodeficiency Virus Infection

    Article • Clinical Infectious Diseases, June 1995, Oxford University Press (OUP)

    Dr Victor Asensi

  104. Clinical Value of Blood Cultures for Detection of Toxoplasma gondii in Human Immunodeficiency Virus-Seropositive Patients with and without Cerebral Lesions on Computerized Tomography

    Article • Clinical Infectious Diseases, September 1993, Oxford University Press (OUP)

    Dr Victor Asensi

  105. Synergistic Effect of Human Lysozyme Plus Ampicillin or  -Lysin on the Killing of Listeria monocytogenes

    Article • The Journal of Infectious Diseases, March 1991, Oxford University Press (OUP)

    Dr Victor Asensi

  106. In vivoInfluence of the Anti-B220 Monoclonal Antibody Administration on the T Cell Differentiation in Mice

    Article • Microbiology and Immunology, April 1989, Wiley

    Dr Victor Asensi